Journal article
Nonarteritic anterior ischemic optic neuropathy with PDE-5 inhibitors for erectile dysfunction
International journal of impotence research, Vol.20(6), pp.537-543
11/2008
DOI: 10.1038/ijir.2008.25
PMID: 18528398
Abstract
Phosphodiesterase type-5 (PDE-5) inhibitors are well tolerated and efficacious treatments for male erectile dysfunction that currently rank among the best-selling drugs worldwide. Since their introduction 10 years ago, there have been a number of reports of patients developing, within hours of PDE-5 inhibitor use, permanent visual loss due to nonarteritic anterior ischemic optic neuropathy (NAION), a common optic neuropathy that results from ischemia of the optic nerve head. In some of the cases, visual loss recurred upon rechallenge with the drug. However, as the bulk of the evidence suggesting a relationship between PDE-5 inhibitor use and NAION comes from case reports and small series, it is difficult to ascertain if a cause-effect relationship truly exists. In this paper, following a review of the transient visual side effects of PDE-5 inhibitors and NAION, we discuss the evidence for and against NAION occurring as a complication of PDE-5 inhibitor use.
Details
- Title: Subtitle
- Nonarteritic anterior ischemic optic neuropathy with PDE-5 inhibitors for erectile dysfunction
- Creators
- M J Thurtell - Department of Neurology, Division of Neuro-Ophthalmology, University Hospitals Case Medical Center, Cleveland, OH 44106, USA. mj.thurtell@gmail.comR L Tomsak
- Resource Type
- Journal article
- Publication Details
- International journal of impotence research, Vol.20(6), pp.537-543
- Publisher
- England
- DOI
- 10.1038/ijir.2008.25
- PMID
- 18528398
- ISSN
- 0955-9930
- eISSN
- 1476-5489
- Language
- English
- Date published
- 11/2008
- Academic Unit
- Neurology; Ophthalmology and Visual Sciences
- Record Identifier
- 9983979994202771
Metrics
87 Record Views